Effect of Sakuranetin on Microglia-Mediated Neuroinflammation After Spinal Cord Injury

Lin-Yu Xiao1,2, Yue Chen1,2, Ting Duan2,3

  • 1Department of Rehabilitation,The First Affiliated Hospital of Bengbu Medical University,Bengbu,Anhui 233004,China.

Insights

Sakuranetin (SK) improves motor function and reduces spinal cord injury (SCI) damage by inhibiting microglial activation and the PI3K/Akt pathway. This study demonstrates SK

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Spinal cord injury (SCI) leads to motor dysfunction and significant tissue damage.
  • Understanding the molecular mechanisms underlying SCI is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the therapeutic effects of sakuranetin (SK) on motor function recovery after SCI in mice.
  • To elucidate the underlying mechanism of SK's action, focusing on inflammation and the PI3K/Akt pathway.

Main Methods:

  • Mice with SCI were treated with SK, and motor function was assessed using behavioral tests.
  • Histological analysis evaluated spinal cord tissue damage.
  • Gene ontology and KEGG pathway analyses predicted SK's mechanism.
  • In vitro and in vivo experiments assessed inflammation, microglial activation, and the PI3K/Akt signaling pathway using qPCR, ELISA, immunofluorescence, and Western blotting.

Main Results:

  • SK treatment significantly improved motor function and reduced lesion size in SCI mice.
  • SK suppressed the release of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) and inhibited microglial activation.
  • SK down-regulated the phosphorylation of PI3K and Akt, indicating inhibition of the PI3K/Akt pathway.

Conclusions:

  • Sakuranetin exhibits neuroprotective effects in a mouse model of spinal cord injury.
  • SK ameliorates SCI-induced inflammation and motor deficits by suppressing microglial activation via the PI3K/Akt pathway.

Related Concept Videos